Chris Lau

Chris Lau

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Exxon Stock Is Very Strongly Positioned for the Long-Term Investor

Exxon stock is falling alongside weak oil prices. The more it falls, the better the opportunity for investors.

Here’s Why Investors Should Buy Micron Stock While It’s Still Down on Dip

Micron should have headed towards the $50 level. That ended abruptly because of the trade war. What should MU stock investors do now?

Alphabet Stock Still Is Very Much a Winning Proposition

Alphabet stock is undervalued by almost 20%. After the recent technology sector selling, Alphabet may rebound faster.

IBM Stock Stronger as Red Hat Adds Fuel for Trillion-Dollar Opportunity

IBM scared off investors with Red Hat costs in year 1. By year 2, free cash flow growth will soar. Why? Higher profits from hybrid cloud opportunity.

It’s Time to Consider Nvidia Stock Again After the Latest Dip

NVDA stock slumped after AMD reported weak quarterly results. Yet the automotive market is a promising area for growth and the long-term case for Nvidia remains intact.